TM & Partners has advised the sellers in connection with the sale of MittVaccin to Cambio

TM & Partners has advised the sellers in connection with the sale of MittVaccin Sverige AB to Cambio Healthcare Systems AB. Through the sale, MittVaccin becomes a subsidiary of Cambio Healthcare Systems and the parties ambition is to jointly accelerate the efforts to achieve MittVaccin’s vision “a patient-safe and efficient handling of vaccinations”.

TM & Partners teams comprised Niclas Högström (Partner), Anna Bjurell (Senior Associate), Mikael Ahlberg (Associate) and Sofia Lindh (Associate).

Back to news